Hypertensive hypertrophic cardiomyopathy of the elderly

Insights

This study identifies a unique cardiac syndrome in elderly hypertensive patients, characterized by severe hypertrophy and supernormal systolic function. Specific medications like beta-blockers and calcium-channel blockers provided symptomatic relief.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Echocardiography

Background:

  • Identified a unique syndrome in 21 hypertensive patients.
  • Syndrome characterized by severe concentric cardiac hypertrophy, small left ventricular cavity, and supernormal systolic function.
  • Patients presented with dyspnea or chest pain, with a history of hypertension.

Purpose of the Study:

  • To characterize a unique subset of hypertensive patients with specific cardiac findings.
  • To investigate the clinical presentation and cardiac function in this patient group.
  • To evaluate the efficacy of different medications for symptomatic relief.

Main Methods:

  • Utilized echocardiography to assess cardiac structure and function.
  • Compared 21 hypertensive patients with age- and sex-matched normotensive controls.
  • Analyzed systolic and diastolic function parameters, including ejection fraction and diastolic filling patterns.

Main Results:

  • Hypertensive patients exhibited significantly higher ejection fractions (79% vs. 59%) and abnormal diastolic function.
  • Abnormal diastolic function included prolonged early diastolic filling and reduced peak diastolic dimension increase.
  • Beta-receptor antagonists or calcium-channel blockers provided symptomatic relief in all treated patients.

Conclusions:

  • This unique subset of hypertensive patients presents a distinct clinical syndrome.
  • The syndrome warrants specific recognition and tailored management strategies.
  • Careful medication selection is crucial, as vasodilators caused severe hypotensive reactions.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...